It seems as though Advent has been around for ages. In fact, compared to most other buy-side-focused technology vendors, it has. The San Francisco-based tech firm was founded in 1983, and, in its near 30-year history, has chalked up an astonishing number of buy-side clients, boasting arguably the most successful (and therefore most ubiquitous) single application across buy-side land: its Moxy OMS, of which is has in excess of 850 user firms. But it’s in the portfolio management (and accounting) space where Advent has been cleaning up, driven by its trio of best-of-breed offerings: Geneva, a portfolio management platform for the alternative industry; APX (Advent Portfolio Exchange), a traditional asset management tool; and Axys, an integrated portfolio management, reporting and accounting platform. All three products can be deployed in-house as well as being available via Advent OnDemand, Advent’s Software-as-a-Service offering, a traditional buy-side favorite due to the lower cost of ownership, improved time to market, and regular upgrades. Over the last three years, these three products have accounted for no fewer than five Buy-Side Technology awards, an endorsement of the high esteem in which these applications are held by the global asset management industry.
1 Advent (23.2%)
2 Bloomberg (21%)
3 Charles River Development (15.5%)
Anthony and James delve into how the systematic internalizer regime is shaping up, and then examine the regtech sector.Subscribe to Weekly Wrap emails